Fatal meningitis in a previously healthy young adult caused by Streptococcus pneumoniae serotype 38: An emerging serotype?

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Baker, Carolyn I ^a   Barrozo, Christopher P ^a   Ryan, Margaret A K ^a   Pearse, Lisa A ^b   Russell, Kevin L ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; DEXAMETHASONE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; CASE REPORT; DISEASE SEVERITY; DRUG FORMULATION; EPIDEMIOLOGICAL DATA; FATALITY; HUMAN; HYPOTHESIS; INCIDENCE; MALE; MEDICAL LITERATURE; MENINGOCOCCOSIS; MOLECULAR EVOLUTION; SAILOR; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; ADOLESCENT; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMOCOCCAL MENINGITIS; SEROTYPING;

ADOLESCENT; ANTI-BACTERIAL AGENTS; FATAL OUTCOME; HUMANS; MALE; MENINGITIS, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 25444514531     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-38     Document Type: Article

References (31)

1. Stanek RJ, Mufson MA: A 20-year epidemiological study of pneumococcal meningitis. Clin Infect Dis 1999, 28:1265-72.
2. Facklam RR, Washington JA: From Streptococcus and related catalase-negative Gram-positive cocci. In: Manual of Clinical Microbiology. 5th edition. Edited by Balows A, Hausler WJ, Herman KL, Isenberg HD, Shandomy HJ. Washington, DC: American Society for Microbiology; 1991:238-57.
3. Enright M, Spratt BG: A multi-locus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144:3049-60.
4. Gray, BM, Converse GM, Dillon HC: Serotypes of Streptococcus pneumoniae causing disease. J Infect Dis 1979, 140:979-83.
5. Orange M, Gray BM: Pneumococcal serotypes causing disease in children. The Ped Infect Dis J 1993, 12(3):244-6.
6. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K: Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infec Dis J 2000, 19:187-195.
7. Gertz RE, McEllistrem C, Boxrud DJ, Li Z, Sakota V, Thompson TA, Facklam RR, Besser JM, Harrison LH, Whitney CG, Beall B: Clonal distribution of Invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 2003, 41(9):4194-4216.
8. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG: Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J of Infect Dis 2004, 190:1203-11.
9. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG: Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. JAMA 2001, 285(13):1729-1735.
10. Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR: Pneumococcal conjugate vaccine serotypes and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis 2001, 33:1489-94.
11. Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, Krause V, Murphy D, Roche P, Smith HV, Stewart MG, Stylianopoulos J, Turnidge J: Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002 - implications for vaccine serotype coverage. Commun Dis Intell 2003, 27:478-487.
12. Communicable Disease Unit. Invasive Pneumococcal Disease in Children Aged Under Five Years in Queensland, in 2002. Queensland Health 2003,Sep.
13. Hills SL, Hanna JN, Denise Murphy D: Invasive pneumococcal disease in North Queensland, 2001. Commun Dis Intell 2002, 26(4):520-4.
14. Fenoll A, Asensio G, Jado I, Berrón S, Camacho MT, Ortega M, Casal J: Antimicrobial susceptibility and pneumococcal serotypes. J Antimicrob Chemother 2002, Suppl 50:13-19.
15. CDSC: Invasive pneumococcal infection England and Wales 1999. Commun Dis Rep 2001, CDR Wkly, 11:6-12.
16. National Centre for Streptococcus: Annual Report for April 1, 2002 to March 31, 2003. Retrieved October 2, 2004 from http://www2.provlab.ab.ca/bugs/vlab/ncs/NCS_02-03_ANNUAL_RRT.pdf.
17. Prymula R, Motlova J, Kriz P: Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic. Indian J Med Res 2004, 119:168-170.
18. Kellner JD, Ford-Jones EL, Members of the Toronto Child Care Centre Study Group: Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Arch Pediatr Adolesc Med 1999, 153:495-502.
19. Hausdorff WP, Bryant J, Paradiso PR, Siber GR: Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30:100-21.
20. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR: The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000, 30:122-40.
21. Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J: Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002, 21:1008-16.
22. Hausdorff WB: Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 2002, 161:S135-S139.
23. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG: Clonal Relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003, 187:1424-32.
24. Kellner JD, McGeer A, Cetron MS, Low DE, Butler JC, Matlow A, Talbot J, Ford-Jones EL: The use of Streptooccus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J 1998, 17:279-86.
25. Scott JAG, Hall AJ, Hannington A: Serotype distribution and prevalence of resistance to bezylpenicillin in tree representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin Infect Dis 1998, 27:1442-50.
26. Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP: Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993, 111:27-39.
27. Klugman KP, Koornhof HJ. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis 1988, 158:956-64.
28. Overweg K, Bogaert K, Sluijter M, Yother J, Dankert J, Groot R, Hermans PW: Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates. J Clin Microbiol 2000, 38:4548-53.
29. Guirguis NI, Helmy MF, Mohamed MR, Ali RH: A suggested vaccine formulation for the control of pneumococcal meningitis in Egypt. J Egypt Public Health Assoc 1990; 65:291-303.
30. Taunay AE, Austrian R, Landgraf IM, Vieira MFP, Melles CEA: Sorotipos de Streptococcus pneumoniae isolados de líquido cefalorraquidiano no período de 1977-1988 na cidade de São Paulo, Brasil. Rev Inst Med Trop Sao Paulo 1990, 32:11-5.
31. Sridharan G, John TJ, Lalitha MK, Harrison LH, Steinhoff MC: Serotypes of Streptococcus pneumoniae causing meningitis in southern India: use of new direct latex agglutination antigen detection tests in cerebrospinal fluid. Diagn Microbiol Infect Dis 1994, 18:211-4.